The Everlab Journey and Building Preventative Health
Everlab has raised around A$80 million, including a recent A$65 million Series A, reached 20,000 patients and processed more than 21 million biomarker results. Now, after becoming one of Australia’s fastest-growing preventative health companies, it’s taking the model global. (Everlab)
I first spoke to the Everlab team back in 2023. I loved what they were building then, but at the time there were plenty of skeptics about whether this kind of deeply personalised, data-heavy model of preventative healthcare could ever really work at scale.
Three years later, they’re proving that it can…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.